It has been demonstrated that individuals with FHH are heterozygous, and children within these families with severe neonatal primary hyperparathyroidism (NSHPT) are homozygous for CASR mutations (Janicic et al. 1995; Pollak et al. 1993). The gene discussed is CASR; the disease is neonatal severe primary hyperparathyroidism.